medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2010, Number 1

<< Back Next >>

Rev Invest Clin 2010; 62 (1)

Fish in renal patient’s diet: phosphorus: n-3 fatty acids ratio

Castro-González MI, Miranda-Becerra D

Language: Spanish
References: 53
Page: 44-53
PDF size: 93.75 Kb.


ABSTRACT

Objective. To identify between 24 marine fish species the most beneficial to renal patient evaluating its phosphorus:n- 3 fatty acids ratio. Material and methods. 15 fishes of each specie were randomly selected; they were filleted and homogenized to take 100g to carry out the chemical analysis by triplicate. Crude protein (Pr) was analyzed in kjeltec equipment. Potassium and calcium was detected by atomic absorption and phosphorus (P) in an UV/Visible spectrophotometer. Results. Crude protein (g/100g) values varied from 15 (pompano) up to 28.2 (big head tile-fish). The fishes with highest (P) (mg/100 g) content were pompano (287), Spanish mackerel (274), king mackerel (257), big head tile-fish (255) and pacific barracuda (252). The specie with the lowest ratio (P):n-3 PUFA was slender frostfish (0.09), followed by albacore (0.17), king mackerel (0.40) and Spanish mackerel; the highest was blue bobo (45.20). Fishes with a high n-3 PUFA/g Pr content were albacore (71.20), king mackerel (35.96), Spanish mackerel (32.50) and rooster hind (2.76). Differences were significant (p ‹ 0.05), in (P) content, in fishes classified by the fat content in muscle (mg P/100 g): lean fishes (193), semi fatty fishes (235) and fatty fishes (244). Conclusions. None of the following fishes are recommended in renal patient’s diet by it lowest contribution of n-3PUFA/g of Pr: blue bobo, yellowedge grouper, parrot sandbass. It is suggested to include chilhuil sea catfish, broomtail grouper, yellow tail snapper, southern flounder, parrot sand bass and big head tilefish by their low content of P/g Pr. The following species included regularly in the diet at least thrice a week could be considered beneficial to the general health status of patients.


REFERENCES

  1. 1 . Espinosa CMA, Miranda AP. Evaluación del estado de nutrición en el paciente nefrópata. Nut Clín 2003; 6(3): 237-51. 2, Bustamante AA, Navarro A. Nefroesclerosis arteriolar y fracaso renal agudo por fármacos. En: Terapéutica en enfermedades renales. Manual de Residentes. Sociedad Española de Farmacia Hospitalaria 2008; 447-63p. Internet: http://www.sefh.es/ 01Manual_residentes.php#2. (acceso 4 abril 2008).

  2. Cisneros GA. Factores de riesgo para la progresión del daño renal. Nut Clin 2003; 6(3): 317-19.

  3. Vélez-Salazar I, González-Michaca L, Correa-Rotter R. Alteraciones renales y nutrición. En: Nutriología Médica”. Casanueva E, et al. (eds.). 2a. Ed. México: Editorial Médica Panamericana; 2001, p. 390-409.

  4. Espinosa-Cuevas MA. ¿Por qué es tan importante la intervención dietética durante la enfermedad renal? Nut Clin 2003; 6(3): 207-8.

  5. Pender, F. Renal function and disorders. In: Encyclopedia of Human Nutrition. Vol. 3. Sadler MJ Ed.) UK, Academic Press; 1999, p. 1701-7.

  6. National Renal Diet Professional Guide. 2nd. Ed. Am Diet Assoc 2002.

  7. Vázquez VJ, Espinosa CMA. Preparación y seguimiento nutricional del paciente susceptible de recibir transplante renal y su donador. Nut Clín 2003; 6(3): 262-9.

  8. European Society of Parenteral and Enteral Nutrition (ESPEN). Guidelines on Enteral Nutrition: Adult Renal Failure. Expert Working Group report on nutrition in adult patients with renal insufficiency (part 1 of 2), and European Guidelines for the Nutritional Care of Adult Renal Patients; Europa. Internet: http://www.kdoqi.org (acceso 8 abril 2008).

  9. Panel de expertos FEDESALUD. Guía para el manejo de la enfermedad crónica. Colombia. Internet: http://www.kdoqi.org (acceso 2 agosto 2008).

  10. Castro-González MI, Ojeda VA, Silencio BJ, Cassis NL, Ledesma CH. Perfil lipídico de 25 pescados marinos mexicanos con especial énfasis en sus ácidos grasos n-3 como componentes nutracéuticos. Arch Lat Nut 2004; 54(3): 328-36.

  11. Castro-González MI, Ojeda VA, Montaño BS. Ácidos grasos n- 3 de 18 especies de pescados marinos mexicanos como base para su empleo como alimentos funcionales. Arch Lat Nut 2007; 57(1): 85-93.

  12. Donadio JV. Omega-3 polyunsaturated fatty acids: a potential new treatment of immune renal disease. Mayo Clinic Proceedings 1991; 66:1010-28.

  13. De Caterina R. n-3 fatty acids and renal diseases. Am J Kidney Dis 1994; 24(3): 397-415.

  14. Donadio JV, Grande JP. The role of fish oil/omega-3 fatty acids in the treatment of IgA nephropathy. Semin Nephrol 2004; 24(3): 225-43.

  15. NMX-608-NORMEX-2002. Alimentos. Determinación de proteínas en alimentos. Método de Prueba, México: 2002.

  16. A.O.A.C. Métodos N 968.08(b), 965.17, tabla 965.09, N 968.090(b), 935.13A(a), 987.03, 987.02, 965.09(D).17 th. Edition. USA: Official Methods of Analysis of the Association of Official Analytical Chemists; 2003.

  17. NMX-FF-005-CS-1982. De nomenclatura para las especies de pescados comestibles, marinos y de agua dulce, con demanda comercial en México. Normas mexicanas. Dirección general de normas. Disponible en: http://www.colpos.mx/bancodenormas/ .../NMX-FF-005-CS-1982.PDF

  18. Conapesca. 2009. Sistema informativo de mercados y mariscos boletín semanal de precios frecuentes al menudeo en diversos puntos de cotización. Disponible en: http:// www.conapesca.sagarpa.gob.mx.

  19. Muñoz CM, Chávez VA, Pérez-Gil RF, Castro-González MI, Ávila CA. Los alimentos y sus nutrientes. Tablas de valor nutritivo de alimentos. 2a. Ed. México: McGraw-Hill Interamericana; 2002, p. 203.

  20. United States Department of Agriculture. Agricultural Research Service. Version current 16 May 2008. Internet: http:// www.ars.usda.gov/nutrientdata

  21. Romero PN, Robert CP, Masson SL, Pineda LR. Composición de ácidos grasos y proximal de siete especies de pescado de Isla de Pascua. Arch. Lat. Nutr. 2000; 50(3): 304-8.

  22. Huss HH. El pescado fresco: su calidad y cambios de su calidad. FAO. Documentos técnicos de Pesca 1999; T348: 202.

  23. Rice R. Fish. Nutritional Value. Vol. 3. In: Encyclopedia of Human Nutrition. Sadler MJ. editor. UK, Academic Press; 1999, 793-803.

  24. Castro-González MI, Pérez-Gil RF, Montaño BS, Silencio BJL. Vitaminas y minerales de sardina en salsa de tomate, colectada en las zonas pesqueras del Pacífico mexicano. Arch Lat Nutr 1999; 49(4): 379-83.

  25. Castro-González MI, Pérez-Gil RF. Vitaminas y minerales del atún aleta amarilla (Thunnus albacares) del Pacífico mexicano enlatado en aceite. Arch Lat Nut 1998; 48(3): 265-8.

  26. Mitch WE, Klahr S. Handbook of Nutrition and the Kidney. 4a. Ed. Philadelphia, USA: Lippincott Williams & Wilkins; 2002, p. 356.

  27. Packard DP, Milton JE, Shuler LA, Short RA, Tuttle KR. Implications of chronic kidney disease for dietary treatment in cardiovascular disease. J Ren Nut 2006; 16(3): 259-68.

  28. Svensson M, Schmidt E, Jorgensen K, Christensen J. The effect of n-3 fatty acids on heart rate variability in patients treated with chronic hemodialysis. J Ren Nut 2007; 17(4): 243-9.

  29. Bowden R, Jitomir J, Wilson R, Gentile M. Effects of omega-3 fatty acid supplementation on lípido levels in endstage renal disease patients. J Ren Nut 2009; 19(4): 259-66.

  30. Argote G, González E. Hiperparatiroidismo secundario. Nefr Lat 2004; 11(2):13-22.

  31. Zanetti M, Barazzoni R, Bosutti A, Stocca A, Grassi G, Guarnieri G. Vascular sources of oxidative stress: implications for uremia-related cardiovascular disease. J Ren Nut 2007; 17(1): 53-56.

  32. Galli CN, Risk MR, Camus JM, Cabrera FE. Calcificación arterial y su evaluación funcional en la enfermedad renal crónica. Rev Nefr Dial y Transpl 2004; 24(4): 165-70.

  33. Dusso SA, Arcidiacono VM, Sato T, Álvarez Hernández D, Yang J, González-Suárez I, et al. Molecular basis of parathyroid hyperplasia. J Ren Nut 2007: 17(1): 45-7.

  34. Goto S, Komaba H, Fukagawa M. Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention. Neph Dyal Transp 2008; (Suppl. 3): iii2-iii8.

  35. Donadio JV, Grande J, Bergstralh E, et al. The Long-Term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. J Am Soc Nephrol 1999; 10: 1772-7.

  36. Jia Q, Zhou H, Bennink M, Pestka J. Docosahexaenoic acid attenuates mycotoxin-induced immunoglobulin A nephrophathy, Interleukin-6 transcription, and mitogen-activated protein kinase phosphorylation in mice. J Nutr 2004; 134: 3343-9.

  37. Li H, Ruan X, Powis S, Fernando R, Mon W, Wheeler D, et al. Varghese Z. EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: Evidence for a PPAR-g-dependent mechanism. Kidney International 2005; 67: 867-74.

  38. Donadio JV, Larson TS, Bergstralh EJ, Grande JP. A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy. J Am Soc Nephrol 2001; 12(4): 791-9.

  39. Parinyasiri U, Ong-Ajyooth L, Parichatikanond P, Ong- Ajyooth S, Liammongkolkul S, Kanyog S. Effect of fish oil in oxidative stress, lipid profile and renal fuction in IgA nephropathy. J Med Assoc Thai 2004; 87(2): 143-9 “(abstr)”.

  40. De Caterina R, Caprioli R, Giannessi D, et al. n-3 fatty acids reduce proteinuria in patients with chronic glomerular disease. Kidney Int 1993; 44: 843-50.

  41. Svensson E, Schmidt K, Jørgensen K, Christensen J. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study. Am J Kidney Dis 2004; 44: 77-83.

  42. Levin A, Foley RN. Cardiovascular disease in chronic renal insufficiency. Am J Kidney Dis 2000; 36(Suppl. 3): S24-S30.

  43. Tracy TC. Food lists for patients with kidney disease. J Ren Nut 2004; 14(2):109-13.

  44. http://connectiondev.Iww.com/PRODUCTS/dudek/documents/ PDF´s/2724/20_pp. 601-629.pdf. Nutrition for patients with renal disorders. Nutrition in Clinical Practice.

  45. Pérez LA, Palacios GB. Sistema de alimentos equivalentes para pacientes renales. México: Fondo de Nutrición y Salud, A.C.; 2009, p. 84.

  46. Colman S, Gordon D. Cooking for David: a culinary dialisis cookbook. Morris Press USA: 2000, 272. Consultado en: www.culinarykidneycook.com

  47. Castells PM, Carrascal SE. ¿Qué puedo comer ahora que estoy en el programa de hemodiálisis?… y tengo diabetes? 3a. Ed. España: HG Hospital General de Vic; 2005, p. 18.

  48. Alvárez RM. Elaboración de Menús. Cuaderno de trabajo para pacientes renales. Curso de Posgrado. Enfermedades Renales y Nutrición. Consultado en: www.nutrinfo.com.ar

  49. Sistema Nacional de Información e Integración de Mercados (SNIIM). Mercados Nacionales; Precios de Mercado: Mercados Pesqueros. Secretaría de Economía. Consultado en: http:// www.secofi-sniim.gob.mx/nuevo/. 2009.

  50. Izquierdo P, Torres FG, González E, Barbosa Y, Márquez SE, Allara M. Efecto de dos tipos de cocción sobre la composición química y perfil de ácidos grasos de filetes de corvina (Cysnoscion maracaiboensis). Rev Cient 1999; 9(5): 367-71.

  51. Moradi Y, Bakar J, Syed Muhamad SH, Chen Man Y. Effects of different final cooking methods on physico-chemical properties of breaded fish fillets. Am J of Food Techn 2009; 4(4): 136-45.

  52. Gall LK, Otwell SW, Koburgier AJ, Appledorf H. Effects of four cooking methods on the proximate , mineral and fatty acid composition of fish fillets. J Food Scien 1983; 48(4): 1068-704.

  53. Unusan N. Change in proximate, amino acid and fatty contents in muscle tissue of rainbow trout (Oncorhynchus mykiss) after cooking. Int J Food Scien and Techn 2007; 42(9): 1087-93.




2020     |     www.medigraphic.com